Published date: 24 September 2018
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Diagnostic kits - 33141625
Location of contract
London
Value of contract
£38,100
Procurement reference
tender_126614/714178
Published date
24 September 2018
Closing date
10 September 2018
Contract start date
21 September 2018
Contract end date
21 September 2019
Contract type
Supply contract
Procedure type
Negotiated procedure without prior publication (above threshold)
The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
Public Health England (PHE) has awarded a contract for the provision of H1V-1 LAg-Avidity ElA kits to Sedia Biosciences Corporation, which is used to monitor recent HIV infection in people in newly diagnosed with HIV as part of national Surveillances.
To ensure comparability of data, the same assay is required over time to minimise any variation between assays performance. Sedia LAg assays are used to monitor recent infections in the UK. Sedia Biosciences Corporation is the only manufacturer of the Sedia LAg assay. Alternative LAg assays have been shown to have different performance characteristics following evaluation. Sufficient data have been generated on
the Sedia LAg assay to confirm that it meets our performance characteristics and that these data are in line with that published by the manufacturer including an MDRI of approx. 130 days at a normalised ODn of 1.5.
More information
Additional text
-
VEAT notice details:
OJEU Document Number
2018/S 167-380498
Notice Reference
2018-041795
Award information
Awarded date
21 September 2018
Contract start date
21 September 2018
Contract end date
21 September 2019
Total value of contract
£38,100
This contract was awarded to 1 supplier.
Sedia Biosciences Corporation
Address
4900 NE 122nd Avenue Portland, OR 97230-1049 US
Reference
None
Supplier is SME?
No
Supplier is VCSE?
No
Share this notice
Closing: 10 September 2018
All content is available under the
